Hifas da Terra (HdT) and Cuevas y Cía announced the results of the trial carried out at the Foltra Health Centre (Foltra Foundation), which shows that the daily intake of a new functional food has a significant impact on critical aspects of neurological health such as memory and attention, and may also be useful in cognitive impairment associated with conditions such as Alzheimer’s disease.
The overall objective of the R&D&I project ‘NutriGen 4.0’ is to design a biotechnological process, which can monitor, simulate and predict outcomes so nutraceuticals can be created by means of advanced calculation and modelling tools.
There are multiple situations that compromise your immunity and the state of your gut microbiota is one of the most important. Find out why you should take care of the microorganisms that inhabit your digestive tract and what foods and nutrients help you to do this.
Hifas da Terra’s released the preliminary results of the trial of mycotherapeutic supplements in nursing home residents diagnosed with COVID-19, which demonstrated that supplementation with immunomodulatory nutraceuticals can significantly improve the situation of those most vulnerable to the pandemic by reducing both mortality and complications associated with infection by SARS-COV-2.
Stress is your body’s response to a changing situation. So far there is no problem, but what happens if it lasts longer than expected? Migraines, digestive problems, tiredness and hypertension that can affect your long-term health.
A pilot study conducted in Barcelona by Hifas da Terra and OAFI analyses the effects of the use of mushroom extracts in cases of osteoarthritis, also known as arthrosis. The complementary treatment with mushrooms has reduced the pain and inflammation as well as the patient´s mobility problems.
The key to the prevention of cognitive impairment could be in the unique antioxidant and anti-inflammatory substances that mushrooms contain. The conclusions of this research indicate a regular consumption could prevent by 50% the problems associated with mild cognitive impairment (MCI) such as memory loss, speech or attention difficulties, etc.